We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $246M
1-Year Est. Return 35.95%
This Fund
S&P 500
This Quarter Est. Return
+10.64%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
–
AUM
$245M
AUM Growth
+$18.2M
Cap. Flow
+$2.74M
Cap. Flow %
1.12%
Top 10 Hldgs %
66.41%
Holding
667
New
60
Increased
182
Reduced
81
Closed
82

Top Buys

Rank Stock Value
1
AXGN icon
Axogen
AXGN
+$3.91M
2
SIBN icon
SI-BONE Inc
SIBN
+$2.35M
3
NEO icon
NeoGenomics
NEO
+$1.8M
4
MASS icon
908 Devices
MASS
+$1.68M
5
HCAT icon
Health Catalyst
HCAT
+$1.18M

Top Sells

Rank Stock Value
1
PHLT
Performant Healthcare Inc
PHLT
+$5.84M
2
ANAB icon
AnaptysBio
ANAB
+$1.6M
3
INSM icon
Insmed
INSM
+$1M
4
ATEC icon
Alphatec Holdings
ATEC
+$740K
5
WFC icon
Wells Fargo
WFC
+$539K

Sector Composition

Rank Sector Weight
1 Healthcare 22.08%
2 Financials 4.47%
3 Technology 3.55%
4 Industrials 1.31%
5 Consumer Discretionary 1.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACWI icon
101
iShares MSCI ACWI ETF
ACWI
$32.4B
$125K 0.05%
885
+8
+0.9% +$1.12K
RBA icon
102
RB Global
RBA
$21.9B
$124K 0.05%
1,205
– –
IUSG icon
103
iShares Core S&P US Growth ETF
IUSG
$31B
$124K 0.05%
736
+725
+6,591% +$121K
QDEL icon
104
QuidelOrtho
QDEL
$1.14B
$123K 0.05%
4,290
– –
MA icon
105
Mastercard
MA
$496B
$120K 0.05%
211
– –
CSCO icon
106
Cisco
CSCO
$452B
$117K 0.05%
1,516
+37
+3% +$2.75K
WST icon
107
West Pharmaceutical
WST
$23.8B
$116K 0.05%
420
– –
PFE icon
108
Pfizer
PFE
$144B
$109K 0.04%
4,393
+112
+3% +$2.82K
HBAN icon
109
Huntington Bancshares
HBAN
$34.6B
$106K 0.04%
6,131
+154
+3% +$2.53K
TYL icon
110
Tyler Technologies
TYL
$13.7B
$99.6K 0.04%
220
+5
+2% +$2.38K
SHY icon
111
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$99.1K 0.04%
1,197
+15
+1% +$1.24K
O icon
112
Realty Income
O
$61.8B
$98.5K 0.04%
1,747
-89
-5% -$5.15K
VXUS icon
113
Vanguard Total International Stock ETF
VXUS
$153B
$98.2K 0.04%
1,302
+121
+10% +$9.04K
VLO icon
114
Valero Energy
VLO
$89.3B
$97.7K 0.04%
600
– –
IBB icon
115
iShares Biotechnology ETF
IBB
$9.48B
$92.4K 0.04%
547
– –
IMCB icon
116
iShares Morningstar Mid-Cap ETF
IMCB
$1.67B
$91.9K 0.04%
1,111
– –
VEEV icon
117
Veeva Systems
VEEV
$32.7B
$90.9K 0.04%
407
– –
WMT icon
118
Walmart Inc
WMT
$903B
$88.5K 0.04%
794
-152
-16% -$16.3K
XLE icon
119
State Street Energy Select Sector SPDR ETF
XLE
$38.4B
$87.3K 0.04%
1,952
+4
+0.2% +$178
CSGP icon
120
CoStar Group
CSGP
$12.7B
$87.1K 0.04%
1,296
– –
CVX icon
121
Chevron
CVX
$375B
$85.9K 0.04%
564
-74
-12% -$11.3K
ZM icon
122
Zoom
ZM
$26.8B
$83.9K 0.03%
972
– –
MAR icon
123
Marriott International
MAR
$101B
$80.3K 0.03%
259
+1
+0.4% +$286
IWO icon
124
iShares Russell 2000 Growth ETF
IWO
$14.3B
$77.9K 0.03%
241
-47
-16% -$15.3K
EFG icon
125
iShares MSCI EAFE Growth ETF
EFG
$16.3B
$76.6K 0.03%
672
+3
+0.4% +$344
3 4
5
6 7

Similar funds

PPA
Pilgrim Partners Asia Singapore $246M AUM
IRP
Investment Research Partners Lemont, Pennsylvania $246M AUM
EPIM
Equinox Partners Investment Management Stamford, Connecticut $245M AUM 225.58% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
RPCONE
Retirement Planning Company of New England Warwick, Rhode Island $246M AUM 27.83% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
VPA
Vernal Point Advisors San Francisco, California $246M AUM 12.97% 1-Year Est. Return

HighMark Wealth Management's Q4 2025 Portfolio in Review

As of Q4 2025, HighMark Wealth Management held 667 positions worth $245M, up 8% from $227M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

HighMark Wealth Management's Q4 2025 filing shows 60 new, 182 increased, 81 reduced and 82 closed positions. Its largest new stake was 908 Devices: 241,000 shares worth $1.27M. The largest sale was Performant Healthcare Inc, an estimated $5.84M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 18% a quarter earlier, followed by Financials and Technology.

  • HighMark Wealth Management's largest Q4 2025 buy was 908 Devices: 241,000 shares worth $1.27M.
  • HighMark Wealth Management added most to Axogen in Q4 2025, an estimated $3.91M increase.
  • HighMark Wealth Management's biggest Q4 2025 reduction was AnaptysBio, cutting an estimated $1.6M.
  • HighMark Wealth Management fully exited Performant Healthcare Inc in Q4 2025, selling an estimated $5.84M.
  • HighMark Wealth Management's ten largest holdings make up 66% of its $245M portfolio in Q4 2025.
  • HighMark Wealth Management opened 60 new positions and closed 82 in Q4 2025.
  • HighMark Wealth Management's portfolio value rose 8% quarter-over-quarter to $245M.

Based on HighMark Wealth Management's 13F filing for Q4 2025, filed 5 Feb 2026.